GlassScriptPhysician profile
Zeeshan Anwar
NPI 1821521030
$2,433.87
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,142 · 2020: $104 · 2021: $436 · 2022: $62.87 · 2023: $87.33 · 2024: $601.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $583 · Food and Beverage: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $582.85 |
| Food and Beverage | $105.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amniox Medical, INC. | $670.56 | 2019 | |
| Treace Medical Concepts, INC. | $600.63 | 2024 | |
| Biotissue Holdings INC. | $292.33 | 2019 | |
| Organogenesis INC. | $141.85 | 2020-2021 | |
| Stryker Corporation | $118.05 | 2019-2022 | |
| Smith+Nephew, INC. | $92.62 | 2021-2023 | Collagenase Santyl |
| Melinta Therapeutics, LLC | $77.11 | 2021 | |
| Embody, INC. | $57.32 | 2021 | |
| Depuy Synthes Sales INC. | $50.11 | 2019-2020 | |
| Next Science LLC | $43.19 | 2023 | Surgx, Xperience, Blastx |
| Horizon Therapeutics Plc | $36.62 | 2021 | |
| Kci USA, INC. | $35.95 | 2021-2023 | Promogran Prisma, Silvercel, 3m Coban |
| Cardiovascular Systems INC. | $30.29 | 2019 | |
| Dynasplint Systems INC. | $28.02 | 2020 | |
| Bioventus LLC | $24.87 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $23.28 | 2019 | |
| Paratek Pharmaceuticals, INC. | $22.50 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $20.18 | 2022 | |
| Kerecis Limited | $19.20 | 2021 | |
| Acell, INC. | $18.34 | 2019 | |
| Alfasigma USA, INC. | $16.35 | 2021 | |
| Zimmer Biomet Holdings, INC. | $14.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zeeshan Anwar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.